Novo Nordisk: the pharma giant making Denmark rich from US obesity epidemic

Producer of weight-loss wonder-drugs Ozempic and Wegovy now valued at more than entire Danish economy

An Ozempic injection pen
One weekly shot of Wegovy can reduce an adult’s body weight by, on average, around 15% over a year
(Image credit: Jaap Arriens/NurPhoto via Getty Images)

Soaring demand for two weight-loss wonder-drugs developed by a Danish pharmaceutical company is having a knock-on effect on the whole of Denmark’s economy.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Explore More